Modafinil in schizophrenia: Is the risk worth taking?

Daniel Neto, Carla Spínola, Joaquim Gago

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Schizophrenia is a severe mental disorder characterised by positive and negative symptoms. Negative symptoms are difficult to treat and there is no specific treatment. In small trials, modafinil has been studied in association with antipsychotic treatment. We present three cases of its use; two have developed positive symptoms and one developed renal impairment. Further studies are needed to assess its usefulness in schizophrenia and safety in this group of patients.

Original languageEnglish
Article numberbcr-2017-219218
JournalBMJ case reports
Volume2017
DOIs
Publication statusPublished - Jun 2017

    Fingerprint

Keywords

  • drugs: psychiatry
  • schizophrenia

Cite this